WO2008002640A3 - Methods and systems for analysis of nutraceutical associated components - Google Patents

Methods and systems for analysis of nutraceutical associated components Download PDF

Info

Publication number
WO2008002640A3
WO2008002640A3 PCT/US2007/014994 US2007014994W WO2008002640A3 WO 2008002640 A3 WO2008002640 A3 WO 2008002640A3 US 2007014994 W US2007014994 W US 2007014994W WO 2008002640 A3 WO2008002640 A3 WO 2008002640A3
Authority
WO
WIPO (PCT)
Prior art keywords
analysis
systems
methods
associated components
nutraceutical associated
Prior art date
Application number
PCT/US2007/014994
Other languages
French (fr)
Other versions
WO2008002640A2 (en
Inventor
John D Rinaldo
Edward K Y Jung
Lowell L Wood
Mark A Malamud
Robert W Lord
Eric C Leuthardt
Royce A Levien
Original Assignee
Searete Llc
John D Rinaldo
Edward K Y Jung
Lowell L Wood
Mark A Malamud
Robert W Lord
Eric C Leuthardt
Royce A Levien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/478,296 external-priority patent/US20070124218A1/en
Priority claimed from US11/515,357 external-priority patent/US8340944B2/en
Priority claimed from US11/523,766 external-priority patent/US20070124175A1/en
Priority claimed from US11/523,809 external-priority patent/US20070124176A1/en
Priority claimed from US11/637,638 external-priority patent/US7927787B2/en
Application filed by Searete Llc, John D Rinaldo, Edward K Y Jung, Lowell L Wood, Mark A Malamud, Robert W Lord, Eric C Leuthardt, Royce A Levien filed Critical Searete Llc
Publication of WO2008002640A2 publication Critical patent/WO2008002640A2/en
Publication of WO2008002640A3 publication Critical patent/WO2008002640A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The present disclosure relates to methods and systems that may be used for analysis of nutraceutical associated components.
PCT/US2007/014994 2006-06-28 2007-06-26 Methods and systems for analysis of nutraceutical associated components WO2008002640A2 (en)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US11/478,296 US20070124218A1 (en) 2005-11-30 2006-06-28 Computational and/or control systems related to individualized nutraceutical selection and packaging
US11/478,341 2006-06-28
US11/478,341 US20070124219A1 (en) 2005-11-30 2006-06-28 Computational and/or control systems related to individualized nutraceutical selection and packaging
US11/478,296 2006-06-28
US11/515,357 US8340944B2 (en) 2005-11-30 2006-09-01 Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US11/515,357 2006-09-01
US11/523,766 US20070124175A1 (en) 2005-11-30 2006-09-18 Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US11/523,809 US20070124176A1 (en) 2005-11-30 2006-09-18 Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US11/523,766 2006-09-18
US11/523,809 2006-09-18
US11/637,638 US7927787B2 (en) 2006-06-28 2006-12-11 Methods and systems for analysis of nutraceutical associated components
US11/637,638 2006-12-11

Publications (2)

Publication Number Publication Date
WO2008002640A2 WO2008002640A2 (en) 2008-01-03
WO2008002640A3 true WO2008002640A3 (en) 2008-11-06

Family

ID=38846311

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/014994 WO2008002640A2 (en) 2006-06-28 2007-06-26 Methods and systems for analysis of nutraceutical associated components

Country Status (1)

Country Link
WO (1) WO2008002640A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016124755B3 (en) 2016-12-19 2018-02-15 Liaver Gmbh & Co. Kg Sound-absorbing component with deletion profiles and sound insulation wall

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030229455A1 (en) * 1999-06-28 2003-12-11 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030229455A1 (en) * 1999-06-28 2003-12-11 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles

Also Published As

Publication number Publication date
WO2008002640A2 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
WO2008073446A3 (en) Methods and systems related to transmission of nutraceutical associated information
WO2007054623A3 (en) Mammalian hedgehog signaling inhiabitors
WO2007148300A3 (en) Methods and systems for push-to-storage
WO2009099719A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
EP1986702A4 (en) Hyperpolarization methods, systems and compositions
WO2011047087A3 (en) Protein detection via nanoreporters
WO2012068105A3 (en) Compositions and uses thereof in converting contaminants
EP1984628A4 (en) Multi-stage compression system and method of operating the same
AU2005331453A1 (en) Systems and methods for tethered turbines
EP2257669A4 (en) Ionic liquid systems for the processing of biomass, their components and/or derivatives, and mixtures thereof
WO2006102295A3 (en) Child-oriented computing facilities
EP2131290A4 (en) Method of displaying related keyword and system as the same
EP2309938A4 (en) Cryo-surgical systems and methods of using the same
WO2008094621A3 (en) Methods for allergen detection
WO2008036317A3 (en) Systems and methods for pathogen detection and response
WO2008011433A3 (en) Styrenated terpene resin as well as methods of making and using the same
WO2008066869A3 (en) Systems and methods for monitoring the amplification and dissociation behavior of dna molecules
WO2007146445A3 (en) Individualized pharmaceutical selection and packaging
WO2008033333A3 (en) Il-1 family variants
WO2010065586A3 (en) Preparation of capecitabine
WO2010048710A8 (en) Neurotoxic sterol glycosides
WO2011088272A9 (en) Selective ampd2 inhibitors and methods for using the same
EG25152A (en) Method for producing an oil-binding agent and oil-binding agent produced according to said method.
WO2010068717A3 (en) Pyrazolinone scavengers of free radicals
WO2008002640A3 (en) Methods and systems for analysis of nutraceutical associated components

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07809980

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07809980

Country of ref document: EP

Kind code of ref document: A2